Since 1995, the Northwest Clinical Research Center has partnered with the pharmaceutical industry to conduct clinical research trials and is dedicated to providing quality medical treatment and patient safety. Each patient receives psychological assessments and health evaluations by our medical staff. Our specialty is psychiatry and the treatment of mood disorders.
Arif Khan, M.D., Medical Director and Principal Investigator at the Center, is a Board Certified Psychiatrist and an Adjunct Professor of Psychiatry at Duke University School of Medicine.
Dr. Khan has published more than 150 scientific papers. He serves as a reviewer for such journals as The Archives of General Psychiatry, The American Journal of Psychiatry, and Biological Psychiatry. He was extensively involved in research leading to the development of medications such as Prozac, Zoloft, Paxil, Wellbutrin, Effexor, Serzone, Remeron, Celexa, Buspar, Zyprexa, Risperdal, Seroquel, Lexapro, Cymbalta, and Abilify. He continues an active research career and presents his work at national and international scientific meetings.
Arifulla Khan, MD
Director-NWCRC
Address:
Northwest Clinical Research Center
1951 - 152nd Place NE
Bellevue, WA 98007
Phone: Northwest Clinical Research Center - (877) 453-0404
Fax: (425) 453-1033
More information about Dr Khan, Principle Investigator, NWCRC: